Psilocybin and its effects on brain connectivity offer potential mental health benefits, particularly in treating depression and enhancing psychotherapy outcomes.
Psychedelic drugs have great therapeutic benefit if understood on their own terms | Ross Ellenhorn and Dimitri Mugianis
An advisory panel rejected MDMA-assisted therapy for PTSD, impacting FDA approval of ecstasy. The rejection is viewed as a significant setback for the psychedelic movement.